Torrent Pharmaceuticals is currently trading at Rs. 1712.30, up by 2.70 points or 0.16% from its previous closing of Rs. 1709.60 on the BSE.
The scrip opened at Rs. 1707.60 and has touched a high and low of Rs. 1716.10 and Rs. 1703.90 respectively. So far 680 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 1964.00 on 29-Mar-2019 and a 52 week low of Rs. 1453.00 on 23-Jul-2019.
Last one week high and low of the scrip stood at Rs. 1744.45 and Rs. 1693.00 respectively. The current market cap of the company is Rs. 28831.47 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 18.80% and 9.95% respectively.
Torrent Pharmaceuticals has issued Non-Convertible Debentures (NCDs) on Private Placement basis for an amount of Rs 300 crore on September 16, 2019. The tenure of the instrument is 1080 days and will mature on August 31, 2022.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.